Press Releases
Public Relations: DNAnexus Press
May 19, 2026
New
DNAnexus Scales AI-Driven Capabilities
17-Year Multiomics Pioneer Powers Next Era of Precision Health
May 07, 2026
DNAnexus Wins MedTech Breakthrough’s PharmaTech Innovation Award
Enterprise Leading Orchestration Platform Honored for AI-Enabled Infrastructure and Next-Gen Digital Health & Medical Technology
May 07, 2026
Longitude Prize on ALS Announces Stage 1 Discovery Award Winners
Meet the Discovery Awardees of the Longitude Prize on ALS, awarded £100,000 each, as well as access to the Prize datasets and a technical support package to drive their computational work. These 20 pioneering, global and multidisciplinary teams are using cutting-edge AI to unlock the complexity of ALS.
November 10, 2025
EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform
EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.
October 22, 2025
DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award
DNAnexus earned recognition from Frost & Sullivan for its leadership in precision health informatics. The award highlights its groundbreaking platform for integrating complex clinical, multi-omics, and real-world data to deliver secure, actionable insights.
September 11, 2025
DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care
Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history within Oracle Health EHR.
August 27, 2025
DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
August 14, 2025
DNAnexus & Boehringer Ingelheim Named 2025 Prix Galien USA Nominee in Best Digital Health Solution for Project PRISM/Project CRYPTx
This recognition highlights an emerging model for dynamic, cloud-based regulatory collaboration.
June 25, 2025
£7.5 million Longitude Prize on ALS launches
The Longitude Prize on ALS, a £7.5 million global challenge prize, has launched to incentivise and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis), the most common form of MND (motor neurone disease).
May 20, 2025
ARPA-H pioneers game-changing cancer care designed to adapt throughout treatment
Selected performer teams will use predictive models to match treatments with changing tumor biology and prevent disease progression.
May 01, 2025
Latin-American genetic data available securely to approved researchers worldwide
Genetic data from the largest blood-based prospective study of a Latin-American population are now available securely to academic researchers worldwide through the DNAnexus Trusted Research Environment (TRE).
March 24, 2025
DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis
AlidaBio EpiPlex™ customers now have cloud access to the EpiScout™ analysis software on DNAnexus’ secure, scalable precision health data cloud platform
February 03, 2025
DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration
Companies come together to connect sponsors, agencies, and standards development organizations on a regulatory collaboration cloud
December 18, 2024
DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data
Frost & Sullivan researched the bioinformatics-based drug discovery and development industry, and based on its analysis results, today recognized DNAnexus, provider of the leading enterprise platform for precision health data, with the 2024 Global Enabling Technology Leadership Award in the "bioinformatics-based drug discovery and development industry" category.
December 09, 2024
DNAnexus and Panomics Join Forces to Deliver Comprehensive, Interactive Multi-omics Data Solutions for Biopharma Organizations
Researchers can conduct large-scale transcriptomics and proteomics data analyses on secure, cloud-based platform to accelerate biomarker discovery and drug repurposing applications.